Norway vs Slovakia: Proportion of isolates with decreased susceptibility or resistance
Norway
0
in 2018
Slovakia
0
in 2018
Norway rank
15th
Slovakia rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Norway
- Slovakia
How they compare
Norway currently reports 0 against 0 in Slovakia, a difference of 0.
The two have swapped places 7 times across 10 shared years of data; in 2009 it was Norway ahead.
Norway ranks 15th and Slovakia ranks 15th of 27 countries.
Across the 2 decades both report, Norway averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Norway | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9091 | 0 | 0.9091 | Norway |
| 2010s | 2.98 | 7.52 | 4.54 | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Norway or Slovakia?
- Norway, at 0 against 0 in Slovakia as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Norway and Slovakia?
- 0, with Norway ahead.
- How many years of comparable data are there for Norway and Slovakia?
- 10 years are reported by both, from 2009 to 2018.
- How do Norway and Slovakia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Norway ranks 15th and Slovakia ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.